Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9299 |
High Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.9236 |
High Similarity |
NPD1934 |
Approved |
0.8938 |
High Similarity |
NPD2801 |
Approved |
0.8909 |
High Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.8909 |
High Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.8909 |
High Similarity |
NPD6166 |
Phase 2 |
0.8862 |
High Similarity |
NPD7054 |
Approved |
0.881 |
High Similarity |
NPD7074 |
Phase 3 |
0.881 |
High Similarity |
NPD7472 |
Approved |
0.875 |
High Similarity |
NPD4380 |
Phase 2 |
0.875 |
High Similarity |
NPD5844 |
Phase 1 |
0.8743 |
High Similarity |
NPD7473 |
Discontinued |
0.8727 |
High Similarity |
NPD6959 |
Discontinued |
0.8726 |
High Similarity |
NPD1511 |
Approved |
0.8675 |
High Similarity |
NPD6232 |
Discontinued |
0.8667 |
High Similarity |
NPD5494 |
Approved |
0.8616 |
High Similarity |
NPD1512 |
Approved |
0.8598 |
High Similarity |
NPD3882 |
Suspended |
0.8596 |
High Similarity |
NPD7251 |
Discontinued |
0.8589 |
High Similarity |
NPD7819 |
Suspended |
0.858 |
High Similarity |
NPD3818 |
Discontinued |
0.8553 |
High Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.8547 |
High Similarity |
NPD7808 |
Phase 3 |
0.8545 |
High Similarity |
NPD7075 |
Discontinued |
0.8538 |
High Similarity |
NPD6797 |
Phase 2 |
0.8537 |
High Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.8537 |
High Similarity |
NPD3817 |
Phase 2 |
0.8485 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.8476 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.8439 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.8434 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.8421 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.8344 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.8344 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.8323 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.8291 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.8253 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.8193 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.8171 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.8165 |
Intermediate Similarity |
NPD2796 |
Approved |
0.8156 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.8133 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.8101 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.8098 |
Intermediate Similarity |
NPD2534 |
Approved |
0.8098 |
Intermediate Similarity |
NPD2533 |
Approved |
0.8098 |
Intermediate Similarity |
NPD2532 |
Approved |
0.8072 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.8066 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.8011 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7975 |
Intermediate Similarity |
NPD1607 |
Approved |
0.7963 |
Intermediate Similarity |
NPD3750 |
Approved |
0.795 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7941 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7937 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7937 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7931 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7927 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7895 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7889 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7882 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7877 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7877 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7861 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7861 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.7849 |
Intermediate Similarity |
NPD919 |
Approved |
0.7849 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7848 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7848 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7848 |
Intermediate Similarity |
NPD1240 |
Approved |
0.7841 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7818 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7798 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7784 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7778 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7764 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7747 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.7744 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.774 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7736 |
Intermediate Similarity |
NPD943 |
Approved |
0.7714 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7707 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7683 |
Intermediate Similarity |
NPD2800 |
Approved |
0.7672 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7672 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7672 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7672 |
Intermediate Similarity |
NPD6779 |
Approved |
0.7672 |
Intermediate Similarity |
NPD6781 |
Approved |
0.7672 |
Intermediate Similarity |
NPD6780 |
Approved |
0.7672 |
Intermediate Similarity |
NPD6782 |
Approved |
0.767 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7665 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7665 |
Intermediate Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.7661 |
Intermediate Similarity |
NPD37 |
Approved |
0.7658 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7658 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.7657 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7654 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7644 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7643 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7636 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.763 |
Intermediate Similarity |
NPD4965 |
Approved |
0.763 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.763 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7629 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.7614 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7614 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7607 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7607 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7588 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7576 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7571 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7569 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.7552 |
Intermediate Similarity |
NPD7696 |
Phase 3 |
0.7552 |
Intermediate Similarity |
NPD7697 |
Approved |
0.7552 |
Intermediate Similarity |
NPD7698 |
Approved |
0.7551 |
Intermediate Similarity |
NPD7783 |
Phase 2 |
0.7551 |
Intermediate Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.7546 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.7527 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.7513 |
Intermediate Similarity |
NPD7870 |
Phase 2 |
0.7513 |
Intermediate Similarity |
NPD7871 |
Phase 2 |
0.75 |
Intermediate Similarity |
NPD6823 |
Phase 2 |
0.75 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD4363 |
Phase 3 |
0.75 |
Intermediate Similarity |
NPD4360 |
Phase 2 |
0.7487 |
Intermediate Similarity |
NPD7701 |
Phase 2 |
0.7471 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7471 |
Intermediate Similarity |
NPD920 |
Approved |
0.747 |
Intermediate Similarity |
NPD6674 |
Discontinued |
0.7469 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7459 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7456 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7436 |
Intermediate Similarity |
NPD7584 |
Approved |
0.7427 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7423 |
Intermediate Similarity |
NPD6651 |
Approved |
0.7421 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7411 |
Intermediate Similarity |
NPD7874 |
Approved |
0.7411 |
Intermediate Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.7407 |
Intermediate Similarity |
NPD6535 |
Approved |
0.7407 |
Intermediate Similarity |
NPD6534 |
Approved |
0.7403 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7384 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7382 |
Intermediate Similarity |
NPD7699 |
Phase 2 |
0.7382 |
Intermediate Similarity |
NPD7700 |
Phase 2 |
0.7377 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7375 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7374 |
Intermediate Similarity |
NPD7801 |
Approved |
0.7365 |
Intermediate Similarity |
NPD5698 |
Clinical (unspecified phase) |
0.7365 |
Intermediate Similarity |
NPD1243 |
Approved |
0.7362 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7353 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7337 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7333 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7322 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7318 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7294 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7289 |
Intermediate Similarity |
NPD5408 |
Approved |
0.7289 |
Intermediate Similarity |
NPD5404 |
Approved |
0.7289 |
Intermediate Similarity |
NPD5405 |
Approved |
0.7289 |
Intermediate Similarity |
NPD5406 |
Approved |
0.7284 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.7284 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7278 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7268 |
Intermediate Similarity |
NPD2494 |
Approved |
0.7268 |
Intermediate Similarity |
NPD2493 |
Approved |
0.7263 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.7256 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7256 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7256 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7254 |
Intermediate Similarity |
NPD8285 |
Discontinued |
0.7246 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7245 |
Intermediate Similarity |
NPD8319 |
Approved |
0.7245 |
Intermediate Similarity |
NPD8320 |
Phase 1 |
0.7229 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.722 |
Intermediate Similarity |
NPD7907 |
Approved |
0.7219 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7216 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7205 |
Intermediate Similarity |
NPD9494 |
Approved |
0.72 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7195 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7179 |
Intermediate Similarity |
NPD3452 |
Approved |
0.7179 |
Intermediate Similarity |
NPD3450 |
Approved |
0.717 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.717 |
Intermediate Similarity |
NPD4749 |
Approved |
0.7159 |
Intermediate Similarity |
NPD6844 |
Discontinued |
0.7158 |
Intermediate Similarity |
NPD7177 |
Discontinued |
0.7157 |
Intermediate Similarity |
NPD4582 |
Approved |
0.7157 |
Intermediate Similarity |
NPD4583 |
Approved |
0.7152 |
Intermediate Similarity |
NPD1201 |
Approved |
0.7152 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7152 |
Intermediate Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.7126 |
Intermediate Similarity |
NPD4308 |
Phase 3 |
0.7122 |
Intermediate Similarity |
NPD4665 |
Approved |
0.7122 |
Intermediate Similarity |
NPD4111 |
Phase 1 |
0.7119 |
Intermediate Similarity |
NPD5761 |
Phase 2 |
0.7119 |
Intermediate Similarity |
NPD5760 |
Phase 2 |
0.7118 |
Intermediate Similarity |
NPD8166 |
Discontinued |
0.7118 |
Intermediate Similarity |
NPD7003 |
Approved |
0.711
|
Intermediate Similarity |
NPD6273 |
Approved |